Nonsense-mediated and nonstop decay of ribosomal protein S19 mRNA in Diamond-Blackfan anemia†
Andrew Chatr-aryamontri
Department of Biology, University “Tor Vergata,” Roma, Italy
Andrew Chatr-aryamontri and Mara Angelini contributed equally to this work.
Search for more papers by this authorMara Angelini
Department of Biology, University “Tor Vergata,” Roma, Italy
Andrew Chatr-aryamontri and Mara Angelini contributed equally to this work.
Search for more papers by this authorEmanuela Garelli
Department of Pediatrics and Genetics, University of Torino, Torino, Italy
Search for more papers by this authorGil Tchernia
Laboratoire d'hématologie, Faculté de Médecine Paris-sud and INSERM U473, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Search for more papers by this authorUgo Ramenghi
Department of Pediatrics and Genetics, University of Torino, Torino, Italy
Search for more papers by this authorIrma Dianzani
Department of Medical Sciences and Interdisciplinary Research Centre of Autoimmune Diseases (IRCAD), University of Eastern Piedmont, Novara, Italy
Search for more papers by this authorCorresponding Author
Fabrizio Loreni
Department of Biology, University “Tor Vergata,” Roma, Italy
Department of Biology, University “Tor Vergata” 00133 Roma, ItalySearch for more papers by this authorAndrew Chatr-aryamontri
Department of Biology, University “Tor Vergata,” Roma, Italy
Andrew Chatr-aryamontri and Mara Angelini contributed equally to this work.
Search for more papers by this authorMara Angelini
Department of Biology, University “Tor Vergata,” Roma, Italy
Andrew Chatr-aryamontri and Mara Angelini contributed equally to this work.
Search for more papers by this authorEmanuela Garelli
Department of Pediatrics and Genetics, University of Torino, Torino, Italy
Search for more papers by this authorGil Tchernia
Laboratoire d'hématologie, Faculté de Médecine Paris-sud and INSERM U473, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Search for more papers by this authorUgo Ramenghi
Department of Pediatrics and Genetics, University of Torino, Torino, Italy
Search for more papers by this authorIrma Dianzani
Department of Medical Sciences and Interdisciplinary Research Centre of Autoimmune Diseases (IRCAD), University of Eastern Piedmont, Novara, Italy
Search for more papers by this authorCorresponding Author
Fabrizio Loreni
Department of Biology, University “Tor Vergata,” Roma, Italy
Department of Biology, University “Tor Vergata” 00133 Roma, ItalySearch for more papers by this authorCommunicated by Sergio Ottolenghi
Abstract
Mutations in the ribosomal protein (RP)S19 gene have been found in about 25% of the cases of Diamond-Blackfan anemia (DBA), a rare congenital hypoplastic anemia that includes variable physical malformations. Various mutations have been identified in the RPS19 gene, but no investigations regarding the effect of these alterations on RPS19 mRNA levels have been performed. It is well established that mutated mRNA containing a premature stop codon (PTC) or lacking a stop codon can be rapidly degraded by specific mechanisms called nonsense mediated decay (NMD) and nonstop decay. To study the involvement of such mechanisms in DBA, we analyzed immortalized lymphoblastoid cells and primary fibroblasts from patients presenting different kinds of mutations in the RPS19 gene, generating allelic deletion, missense, nonsense, and nonstop messengers. We found that RPS19 mRNA levels are decreased in the cells with allelic deletion and, to a variable extent, also in all the cell lines with PTC or nonstop mutations. Further analysis showed that translation inhibition causes a stabilization of the mutated RPS19 mRNA. Our findings indicate that NMD and nonstop decay affect the expression of mutated RPS19 genes; this may help to clarify genotype–phenotype correlations in DBA. Hum Mutat 24:526–533, 2004. © 2004 Wiley-Liss, Inc.
REFERENCES
- Angelastro JM, Torocsik B, Greene LA. 2002. Nerve growth factor selectively regulates expression of transcripts encoding ribosomal proteins. BMC Neurosci 3: 3.
- Aoyama T, Francke U, Dietz HC, Furthmayr H. 1994. Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. J Clin Invest 94: 130–137.
- Asselta R, Duga S, Spena S, Santagostino E, Peyvandi F, Piseddu G, Targhetta R, Malcovati M, Mannucci PM, Tenchini ML. 2001. Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs. Blood 98: 3685–3692.
- Ball SE, McGuckin CP, Jenkins G, Gordon-Smith EC. 1996. Diamond-Blackfan anaemia in the U.K.: analysis of 80 cases from a 20-year birth cohort. Br J Haematol 94: 645–653.
- Baserga SJ, Benz EJ Jr. 1992. Beta-globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability. Proc Natl Acad Sci USA 89: 2935–2939.
- Brocke KS, Neu-Yilik G, Gehring NH, Hentze MW, Kulozik AE. 2002. The human intronless melanocortin 4-receptor gene is NMD insensitive. Hum Mol Genet 11: 331–335.
- Byers PH. 2002. Killing the messenger: new insights into nonsense-mediated mRNA decay. J Clin Invest 109: 3–6.
- Chang JC, Kan YW. 1979. beta 0 thalassemia, a nonsense mutation in man. Proc Natl Acad Sci USA 76: 2886–2889.
- Da Costa L, Narla G, Willig TN, Peters LL, Parra M, Fixler J, Tchernia G, Mohandas N. 2003a. Ribosomal protein S19 expression during erythroid differentiation. Blood 101: 318–324.
- Da Costa L, Tchernia G, Gascard P, Lo A, Meerpohl J, Niemeyer C, Chasis JA, Fixler J, Mohandas N. 2003b. Nucleolar localization of RPS19 protein in normal cells and mislocalization due to mutations in the nucleolar localization signals in 2 Diamond-Blackfan anemia patients: potential insights into pathophysiology. Blood 101: 5039–5045.
- den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15: 7–12.
10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N CAS PubMed Web of Science® Google Scholar
- Dietz HC, McIntosh I, Sakai LY, Corson GM, Chalberg SC, Pyeritz RE, Francomano CA. 1993. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics 17: 468–475.
- Draptchinskaia N, Gustavsson P, Andersson B, Pettersson M, Willig TN, Dianzani I, Ball S, Tchernia G, Klar J, Matsson H, Tentler D, Mohandas N, Carlsson B, Dahl N. 1999. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 21: 169–175.
- Faliks D, Meyuhas O. 1982. Coordinate regulation of ribosomal protein mRNA level in regenerating rat liver. Study with the corresponding mouse cloned cDNAs. Nucleic Acids Res 10: 789–801.
- Frischmeyer PA, Dietz HC. 1999. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 8: 1893–1900.
- Frischmeyer PA, van Hoof A, O'Donnell K, Guerrerio AL, Parker R, Dietz HC. 2002. An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. Science 295: 2258–2261.
- Gismondi V, Stagnaro P, Pedemonte S, Biticchi R, Presciuttini S, Grammatico P, Sala P, Bertario L, Groden J, Varesco L. 1998. Chain-terminating mutations in the APC gene lead to alterations in APC RNA and protein concentration. Genes Chromosomes Cancer 22: 278–286.
10.1002/(SICI)1098-2264(199808)22:4<278::AID-GCC3>3.0.CO;2-S CAS PubMed Web of Science® Google Scholar
- Hall GW, Thein S. 1994. Nonsense codon mutations in the terminal exon of the beta-globin gene are not associated with a reduction in beta-mRNA accumulation: a mechanism for the phenotype of dominant beta-thalassemia. Blood 83: 2031–2037.
- Halperin DS, Freedman MH. 1989. Diamond-Blackfan anemia: etiology, pathophysiology, and treatment. Am J Pediatr Hematol Oncol 11: 380–394.
- Hamaguchi I, Ooka A, Brun A, Richter J, Dahl N, Karlsson S. 2002. Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia. Blood 100: 2724–2731.
- Ishigaki Y, Li X, Serin G, Maquat LE. 2001. Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20. Cell 106: 607–617.
- Kim VN, Kataoka N, Dreyfuss G. 2001. Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon–exon junction complex. Science 293: 1832–1836.
- Kozak M. 1999. Initiation of translation in prokaryotes and eukaryotes. Gene 234: 187–208.
- Le Hir H, Izaurralde E, Maquat LE, Moore MJ. 2000. The spliceosome deposits multiple proteins 20–24 nucleotides upstream of mRNA exon-exon junctions. EMBO J 19: 6860–6869.
- Losson R, Lacroute F. 1979. Interference of nonsense mutations with eukaryotic messenger RNA stability. Proc Natl Acad Sci USA 76: 5134–5137.
- Maquat LE, Li X. 2001. Mammalian heat shock p70 and histone H4 transcripts, which derive from naturally intronless genes, are immune to nonsense-mediated decay. RNA 7: 445–456.
- Mendell JT, Dietz HC. 2001. When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107: 411–414.
- Nagy E, Maquat LE. 1998. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 23: 198–199.
- Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM, Mazoyer S. 2002. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum Mol Genet 11: 2805–2814.
- Rajavel KS, Neufeld EF. 2001. Nonsense-mediated decay of human HEXA mRNA. Mol Cell Biol 21: 5512–5519.
- Rodningen OK, Tonstad S, Saugstad OD, Ose L, Leren TP. 1999. Mutant transcripts of the LDL receptor gene: mRNA structure and quantity. Hum Mutat 13: 186–196.
10.1002/(SICI)1098-1004(1999)13:3<186::AID-HUMU2>3.0.CO;2-K CAS PubMed Web of Science® Google Scholar
- Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. p 6–9, 22–24.
- Schell T, Kulozik AE, Hentze MW. 2002. Integration of splicing, transport and translation to achieve mRNA quality control by the nonsense-mediated decay pathway. Genome Biol 3: REVIEWS1006.
- Schrijver I, Liu W, Odom R, Brenn T, Oefner P, Furthmayr H, Francke U. 2002. Premature termination mutations in FBN1: distinct effects on differential allelic expression and on protein and clinical phenotypes. Am J Hum Genet 71: 223–237.
- van Hoof A, Frischmeyer PA, Dietz HC, Parker R. 2002. Exosome-mediated recognition and degradation of mRNAs lacking a termination codon. Science 295: 2262–2264.
- Vasudevan S, Peltz SW, Wilusz CJ. 2002. Non-stop decay—a new mRNA surveillance pathway. Bioessays 24: 785–788.
- Vasudevan S, Peltz SW. 2003. Nuclear mRNA surveillance. Curr Opin Cell Biol 15: 332–337.
- Wagner E, Lykke-Andersen J. 2002. mRNA surveillance: the perfect persist. J Cell Sci 115(Pt 15): 3033–3038.
- Willig TN, Draptchinskaia N, Dianzani I, Ball S, Niemeyer C, Ramenghi U, Orfali K, Gustavsson P, Garelli E, Brusco A, Tiemann C, Perignon JL, Bouchier C, Cicchiello L, Dahl N, Mohandas N, Tchernia G. 1999. Mutations in ribosomal protein S19 gene and Diamond-Blackfan anemia: wide variations in phenotypic expression. Blood 94: 4294–4306.
- Zhang J, Maquat LE. 1997. Evidence that translation reinitiation abrogates nonsense-mediated mRNA decay in mammalian cells. EMBO J 16: 826–833.